USPTO serial 86476576
PROGRESS IN MIND
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 5, 2016
- Examiner
- VAGHANI, MAYUR C
- Law office
- —
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with PROGRESS IN MIND?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maren C. Perry
Maren C. Perry King & Spalding LLP1290 Avenue of Americas, 14th FloorNew York, NY 10104United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency; medical diagnostic preparations for medical purposes, reagents for medical use, diagnostic agents preparations and substances for medical purposes] | SECTION 8 - CANCELLED | — |
| 041 | [ [Education services, namely, providing continuing medical education courses; providing of training, namely, medical training and teaching;] arranging and conducting educational seminars, conferences, [symposiums, workshops, training and courses] in the field of medicine; [educational classes, courses, seminars and workshops and training services in the field of research and development for the treatment and prevention of brain and central nervous system diseases and disorders, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention;] educational [services, namely,] seminars, [conferences, symposiums, workshops, training and courses and training services] in the field of medical research and development, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention of disease provided electronically, on-line, via the Internet and global communications networks; education services, namely, arranging and conducting of expert forums, in the form of seminars, conferences, [symposia, workshops and courses] in the field of medicine [; educational services, namely, providing medical training online; providing non-downloadable, on-line publications, namely, books, reports, brochures, booklets, leaflets, including patient information leaflets, magazines, journals, teaching and educational material in the nature of articles, journals in the field of medical research and development, science, clinical tests and trials, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention of disease] ] | SECTION 8 - CANCELLED | — |
| 042 | [Scientific and technological services, namely, scientific research in the field of medicine; industrial analysis in the nature of research services in the field of pharmaceuticals; providing online non-downloadable software in the field of research and development for use in database management in the field of the treatment and prevention of brain and central nervous system diseases and disorder and an online searchable database in the field of scientific research and development of clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention all for the purpose of scientific research; providing a secured-access website that gives registered medical experts the ability to upload, view, download, and share documents and images for the purposes of research and development in the field of clinical tests and trials, science, patient diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention of disease; pharmaceutical research and development; scientific and technological services, namely, research in the field of medical disorders, diseases and prevention of disease; scientific and technological services, namely, scientific research in the field of the treatment and prevention of brain and central nervous system related disorders, diseases and pharmaceuticals; medical research, conducting clinical medical trials and testing in the field of pharmaceuticals for others; medical services, namely, medical research; medical diagnostic research and tests, namely, clinical trials for others; providing medical research information in the field of pharmaceutical research and development, clinical tests and trials] | SECTION 8 - CANCELLED | — |
| 044 | [Medical services in the field of psychiatry and psychology, namely, medical advice related to medical and pharmaceutical preparations and substances; medical clinical services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; medical treatment services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; therapeutic treatment services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; therapeutic clinical services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; healthcare and medical services related to central nervous system and brain disorders, diseases and pharmaceuticals;] providing information relating to diagnostic and therapeutic properties of pharmaceuticals in the field of disorders, diseases, treatment and prevention; providing medical information services; [ providing on-line medical data and analyses designed to provide patients and clients customized information, including medical dose, diagnosis, therapeutic issues and medical management; providing an online database in the field of medical diagnosis and treatment of brain and central nervous system diseases and disorders] | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by H. Lundbeck A/S
- Other trademarks owned by H. Lundbeck A/S
- Other trademarks owned by H. Lundbeck A/S
- Other trademarks in Class 005
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named PROGRESS IN MIND
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 11, 2026 | NP89 | NOTICE OF ACCEPTANCE OF PARTIAL SEC. 8 & 9 EMAILED | — |
| Apr 11, 2026 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Apr 11, 2026 | 9G8P | REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8 | — |
| Apr 11, 2026 | 8PRT | REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED | — |
| Apr 11, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 2, 2026 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Jan 5, 2025 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Mar 22, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 22, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Mar 22, 2024 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Mar 22, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 22, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 16, 2022 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Jun 16, 2022 | 8.PR | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED | — |
| Jun 2, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 29, 2021 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Jan 5, 2021 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 5, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 20, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 20, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 30, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 12, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 9, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 9, 2015 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 9, 2015 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 9, 2015 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 9, 2015 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 19, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 19, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 12, 2015 | ALIE | ASSIGNED TO LIE | — |
| Jul 29, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 10, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 10, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 10, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 10, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 15, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 13, 2014 | NWAP | NEW APPLICATION ENTERED | — |